GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD.

Guangdong Taiantang Pharmaceutical Co., Ltd.

002433

CNE100000Q92

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
0.51 ^CNY	-5.56%		-22.73%	-78.48%

Apr. 29	Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Guangdong Taiantang Plans to Sell Stake in Digital Health Technology Firm

April 21, 2021 at 08:32 pm EDT

Guangdong Taiantang Pharmaceutical Co., Ltd. (SZSE:002433) said it plans to sell 47.35% stake in digital health technology firm for CNY 748.1 million ($115.26 million).

Latest news about Guangdong Taiantang Pharmaceutical Co., Ltd.

Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Approves Board Elections	23-01-20	CI
Shantou Real Estate Hexin Co., Ltd. acquired Shantou Tai'an Investment Development Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for CNY 240 million.	22-12-12	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-15	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Auditor Raises 'Going Concern' Doubt	22-06-14	CI
Shantou Real Estate Hexin Co., Ltd. agreed to acquire Shantou Tai'an Investment Development Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for CNY 240 million.	21-12-13	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Chengdu Yiyun Technology Co., Ltd. completed the acquisition of a 47.35% stake in Guangdong Kangaiduo Digital Health Technology Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd..	21-06-24	CI
Guangdong Hongding Real Estate Investment Development Group Co., Ltd. agreed to acquire 25% stake in Guangzhou Jinpibao Property Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for approximately CNY 220 million.	21-05-21	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Not to Pay Dividend for the Year 2020	21-05-10	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Guangdong Taiantang Plans to Sell Stake in Digital Health Technology Firm	21-04-21	CI
Chengdu Yiyun Technology Co., Ltd. agreed to acquire a 47.35% stake in Guangdong Kangaiduo Digital Health Technology Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for approximately CNY 750 million.	21-04-21	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-09	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-27	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-26	CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Announces 2019 Final Distribution Plan, Payable on 17 July 2020	20-07-09	CI

Chart Guangdong Taiantang Pharmaceutical Co., Ltd.

Duration

Period

Chart Guangdong Taiantang Pharmaceutical Co., Ltd.

More charts

Guangdong Taiantang Pharmaceutical Co Ltd is a company mainly engaged in the manufacturing of Chinese patent medicines and the primary processing of Chinese medicinal materials. The Company operates five segments. Chinese Patent Medicines Manufacturing Business segment is mainly responsible for the production and wholesale of Pibao cream, Qilin pill, Xinbao pill, Xinxin pill, Tongqiao Yixin pill, etc. Primary Processing Business segment of the traditional Chinese medicine materials is mainly responsible for planting, primary processing and sales of the ginseng and traditional Chinese medicine materials. Drug Wholesale and Retail Business segment is mainly responsible for the wholesale and retail of drugs and medical devices. Health Industry Development and Products Sales segment is mainly responsible for the development and sales of health concept real estate products. Medical Services segment is mainly responsible for the in-depth development of medical and elderly care services.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD.	-78.48%	54.01M
DONG-E-E-JIAO CO.,LTD.	+37.08%	6.01B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-17.43%	4.4B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.46%	3.17B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+0.51%	3.07B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.53%	2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.15%	1.88B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-5.15%	1.73B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-10.38%	1.58B